Rebecca L Ross
Overview
Explore the profile of Rebecca L Ross including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
678
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ross R, Caballero-Ruiz B, Clarke E, Kakkar V, Wasson C, Mulipa P, et al.
Rheumatology (Oxford)
. 2024 Dec;
PMID: 39700423
Objective: The Very Early Diagnosis of Systemic Sclerosis (VEDOSS) EUSTAR study showed that, despite not showing any clinical sign of disease, patients with Raynaud's and antinuclear antibodies and/or capillaroscopy abnormalities...
2.
Topping J, Chang L, Nadat F, Poulter J, Ibbotson A, Lara-Reyna S, et al.
Arthritis Rheumatol
. 2024 Nov;
PMID: 39492681
Objective: Adult-onset Still disease (AOSD) is a systemic autoinflammatory disorder (AID) of unknown etiology. Genetic studies have been limited. Here, we conducted detailed genetic and inflammatory biomarker analysis of a...
3.
Bryon J, Wasson C, Koeppen K, Chandler F, Willis L, Di Donato S, et al.
Arthritis Rheumatol
. 2024 Oct;
77(3):322-334.
PMID: 39415484
Objective: Activation of type I interferon (IFN) response has been shown to correlate with disease activity in systemic sclerosis (SSc). It is currently unknown whether the tissue-specific type I IFN...
4.
Chandler F, Reddy P, Bhutda S, Ross R, Datta A, Walden M, et al.
bioRxiv
. 2024 Sep;
PMID: 39282282
Deubiquitylases (DUBs) are crucial in cell signalling and are often regulated by interactions within protein complexes. The BRCC36 isopeptidase complex (BRISC) regulates inflammatory signalling by cleaving K63-linked polyubiquitin chains on...
5.
De Lorenzis E, Mor A, Ross R, Di Donato S, Aricha R, Vaknin I, et al.
Arthritis Care Res (Hoboken)
. 2024 Apr;
76(9):1269-1277.
PMID: 38589291
Background: Systemic sclerosis (SSc) is a heterogeneous disease, characterized by variable tissue and vascular fibrosis in the context of autoimmune activation. CCL24 (or Eotaxin2) has been shown to promote microangiopathic,...
6.
Wasson C, De Lorenzis E, Clavane E, Ross R, Walker K, Caballero-Ruiz B, et al.
J Invest Dermatol
. 2024 Apr;
144(10):2197-2210.e4.
PMID: 38570030
BACE1 is well-known for its role in the development of Alzheimer's disease. Recent publications, including our own, have demonstrated a role for this enzyme in other chronic diseases. The aim...
7.
Kondo M, Suzuki T, Kawano Y, Kojima S, Miyashiro M, Matsumoto A, et al.
Arthritis Res Ther
. 2022 Sep;
24(1):210.
PMID: 36050717
Background: Activation of melanocortin 1 receptor (MC1R) is known to exert broad anti-inflammatory and anti-fibrotic effects. The purpose of this study is to investigate the potential of dersimelagon, a novel...
8.
Ross R, Mavria G, Del Galdo F, Elies J
Front Physiol
. 2022 May;
13:900631.
PMID: 35600300
Systemic sclerosis (SSc) is a terminal disease characterized by vasculopathy, tissue fibrosis, and autoimmunity. Although the exact etiology of SSc remains unknown, endothelial dysfunction, oxidative stress, and calcium handling dysregulation...
9.
Saleem B, Ross R, Bissell L, Aslam A, Mankia K, Duquenne L, et al.
RMD Open
. 2022 Apr;
8(1).
PMID: 35365569
Objectives: To assess antibody and T cell responses to SARS-CoV-2 vaccination in patients with rheumatoid arthritis (RA) on disease-modifying antirheumatic drugs (DMARDs). Methods: This prospective study recruited 100 patients with...
10.
Saleem B, Ross R, Duquenne L, Hughes P, Emery P
Lancet Rheumatol
. 2022 Feb;
4(3):e171-e172.
PMID: 35136863
No abstract available.